Give a special meaning to your wedding or upcoming occasion by making a donation to MSAA and we will provide you with personalized favors for your celebration to announce your gift.
Read News Article
Author: Hoff Communications
Create a Tribute Page
Create a personal fundraising tribute page to honor a friend, remember a loved one, or celebrate a special occasion.
Read News ArticleThe Multiple Sclerosis Association of America Launches Online Support Community for Individuals Affected by MS
The Multiple Sclerosis Association of America (MSAA) announces the official launch of My MSAA Community. Powered by HealthUnlocked, this new online community forum has been created to offer people living […]
Read News Article
Planned Giving
Make a lasting impact and consider a planned gift to MSAA. Planned gifts, such as bequests, estate gifts, or charitable trusts allow donors to support MSAA beyond their lifetime and by offering tax advantages, income, and personal satisfaction.
Read News Article
Honor and Memorial Donations
A gift to MSAA is a thoughtful way to honor or memorialize someone whose life has been affected by MS.
Read News Article
Yankee Candle Holiday Fundraiser
Support MSAA through our 7th Annual Yankee Candle Holiday Fundraiser! Visit yankeecandlefundraising.com and enter group number 990043872 to start shopping.
Read News ArticleHighlights from the AAN and CMSC Annual Meetings
Two vital conferences providing the latest information and research on multiple sclerosis (MS) take place in the spring of each year. These are the American Academy of Neurology (AAN) and […]
Read News ArticleMy MS Manager Named One of the Best MS Apps of 2016
My MS Manager™, MSAA’s free mobile phone app, has been recognized by Healthline.com as one of the best multiple sclerosis (MS) apps for the fourth consecutive year. Healthline editors selected […]
Read News ArticleFDA Accepts Review of Application for Ocrelizumab
On June 27, 2016, Genentech, a member of the Roche group, announced that the Biologics License Application (BLA) for ocrelizumab has been accepted for review by the United States Food […]
Read News ArticleEligible People with PPMS May Receive Experimental Medication
Ocrelizumab, an experimental medication presently under investigation for the treatment of primary-progressive multiple sclerosis (PPMS), will be available for eligible individuals with PPMS through an Expanded Access Program (EAP). An […]
Read News Article